TNF and rheumatoid arthritis: Studies of European patients with RA from the British Society for Rheumatology Biologics Register and from Spanish and Dutch cohorts have also found greater improvement in physical function after switching to rituximab versus an alternative anti-TNF agent [11, 12, 14].